KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bionano Genomics (BNGO) Interest Expenses (2017 - 2024)

Bionano Genomics' Interest Expenses history spans 6 years, with the latest figure at $122000.0 for Q1 2024.

  • For Q1 2024, Interest Expenses rose 60.53% year-over-year to $122000.0; the TTM value through Dec 2024 reached $122000.0, down 97.62%, while the annual FY2023 figure was $5.1 million, 1617.79% up from the prior year.
  • Interest Expenses for Q1 2024 was $122000.0 at Bionano Genomics, down from $4.9 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $4.9 million in Q4 2023 and bottomed at $2000.0 in Q3 2021.
  • The 5-year median for Interest Expenses is $77000.0 (2022), against an average of $528588.2.
  • The largest annual shift saw Interest Expenses crashed 99.66% in 2021 before it soared 6430.67% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $608000.0 in 2020, then plummeted by 96.38% to $22000.0 in 2021, then surged by 240.91% to $75000.0 in 2022, then skyrocketed by 6430.67% to $4.9 million in 2023, then plummeted by 97.51% to $122000.0 in 2024.
  • Per Business Quant, the three most recent readings for BNGO's Interest Expenses are $122000.0 (Q1 2024), $4.9 million (Q4 2023), and $72000.0 (Q3 2023).